S

Shirley Ryan Abilitylab | Chicago, IL

Research site
(Unclaimed)
Location
355 E Erie St, Chicago, Illinois, United States of America
Site insights

Top conditions

Spinal Cord Injuries (29 trials)

Stroke (28 trials)

Wounds and Injuries (18 trials)

Hypoxia (10 trials)

Parkinson Disease (7 trials)

Top treatments

NVG-291
4-AP

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

5 of 106
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
Assessing the DSR Ankle

This research is being done to conduct a preliminary investigation into a new prosthetic microprocessor controlled (MPC) ankle, called the Damping, S...

Enrolling
Amputation
Limb Deficiencies
Device: Predicate Ankle
Device: DSR Ankle

A randomized, repeated measures comparative design study to compare use of a micro-processor controlled knee-ankle-foot orthosis vs. traditional care...

Enrolling
Spinal Cord Injury
Device: C-Brace II
Device: Traditional Care KAFO intervention

A Single site (Shirley Ryan AbilityLab) Randomized, Double-Blind, Placebo-Controlled Phase 1b/2a Study of NVG-291 in Spinal Cord Injury Subjects

Enrolling
Chronic Spinal Cord Injury
Subacute Spinal Cord Injury
Drug: NVG-291

The objective of this study is to develop a virtual rehabilitation system that can be used to effectively treat Phantom Limb Pain (PLP) within the re...

Enrolling
Phantom Pain Following Amputation of Upper Limb
Lower Limb Amputation Knee
Device: Coapt Phantom Limb Pain Management System

The overall objective of this fully powered clinical trial is to investigate if using a solid backrest on a manual wheelchair (MWC) will improve post...

Enrolling
Spinal Cord Injuries
Other: Manual Wheelchair (MWC) backrest configuration

Trial sponsors

Shirley Ryan AbilityLab logo

Shirley Ryan AbilityLab (84 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems